Skip to main content

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash Dividends Charged to Retained Earnings This Quarter (QFR120385USNO)

Observation:

Q3 2024: 13,751 (+ more)  Updated: Dec 10, 2024 9:07 AM CST
Q3 2024:  13,751  
Q2 2024:  18,244  
Q1 2024:  11,978  
Q4 2023:  20,158  
Q3 2023:  11,663  

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

NOTES

Title Release Dates

2017-09-06 2024-12-10
 
Source    

2017-09-06 2024-12-10
 
Release    

2017-09-06 2024-12-10
 
Units    

2017-09-06 2024-12-10
 
Frequency    

2017-09-06 2024-12-10
 
Seasonal Adjustment    

2017-09-06 2024-12-10
 
Notes    

2017-09-06 2024-12-10

RELATED DATA AND CONTENT

Data Suggestions Based On Your Search

Content Suggestions

Related Categories

Releases

Tags